Share
604 Posts.
lightbulb Created with Sketch. 140
clock Created with Sketch. 26/02/21
13:37
Share
Originally posted by Senpras89:
↑
Thanks Kiwinvestor, yes on a paper money basis there has been a loss, but I do not look at the stock every day and you cant lose something you haven't sold - this is a hold and keep type stock.My long term view is around a few simple points, I try to have a very clear thesis: $4 was extremely low to be selling off something of such tremendous value. Value and timelines rarely intersect and this is a deep value play. This should be at minimum ~$1bn given the data that has already come out, I have never seen data that significant come out before a major trial. "a-typical" biotech stock with a totally different risk profile.much more than $4. It would be irresponsible of me to say it will be over $15, but it has that potential and more.
Expand
Another question. Has PR ever mentioned to you what long-term vision he has for the company? It seems to have moved in the last few months from PPS focused to now a repurposing company. Does he have a CSL type vision? Why not just cash his chips in and go and enjoy life or is he the real deal and wanting to build something significant?
(20min delay)